TCHISTIAKOVA; Lioudmila
Patent Applications and Registrations
Patent applications and USPTO patent grants for TCHISTIAKOVA; Lioudmila.The latest application filed is for "single domain binding molecule".
Company Profile
7.28.44
- TCHISTIAKOVA; Lioudmila - Cambridge MA
- Tchistiakova; Lioudmila - Andover MA
- Tchistiakova; Lioudmila - Stoneham MA
- Tchistiakova; Lioudmila - Laval CA
- Tchistiakova; Lioudmila - Bothell WA
Patent Activity
| Patent | Date |
|---|---|
| Single Domain Binding Molecule App 20210332116 - BARELLE; Caroline ; et al. | 2021-10-28 |
| Engineered antibody constant regions for site-specific conjugation and methods and uses therefor Grant 11,147,852 - Marquette , et al. October 19, 2 | 2021-10-19 |
| Single domain binding molecule Grant 11,034,756 - Barelle , et al. June 15, 2 | 2021-06-15 |
| Humanized Antibodies App 20210040182 - Finlay; William James Jonathan ; et al. | 2021-02-11 |
| Humanized antibodies Grant 10,647,756 - Finlay , et al. | 2020-05-12 |
| Bispecific Antibodies App 20200123260 - Bennett; Eric M. ; et al. | 2020-04-23 |
| Antibodies And Antibody Fragments For Site-specific Conjugation App 20200069764 - MA; Dangshe ; et al. | 2020-03-05 |
| Bispecific antibodies Grant 10,392,438 - Bennett , et al. A | 2019-08-27 |
| Single Domain Binding Molecule App 20190194307 - BARELLE; Caroline ; et al. | 2019-06-27 |
| Single domain binding molecule Grant 10,287,341 - Barelle , et al. | 2019-05-14 |
| Bispecific Antibodies App 20180179285 - Bennett; Eric M. ; et al. | 2018-06-28 |
| Anti-5t4 Antibodies And Uses Thereof App 20180162937 - BOGHAERT; Erwin R. ; et al. | 2018-06-14 |
| Method for treating muscle wasting syndrome using antagonist antibodies against GDF-8 Grant 9,926,368 - Walsh , et al. March 27, 2 | 2018-03-27 |
| Anti-5T4 antibodies and uses thereof Grant 9,902,771 - Boghaert , et al. February 27, 2 | 2018-02-27 |
| Antibodies And Antibody Fragments For Site-specific Conjugation App 20170216452 - MA; Dangshe ; et al. | 2017-08-03 |
| Immunotherapy regimes dependent on ApoE status Grant 9,644,025 - Black , et al. May 9, 2 | 2017-05-09 |
| Single Domain Binding Molecule App 20170096475 - BARELLE; Caroline ; et al. | 2017-04-06 |
| Humanized Antibodies App 20170073395 - Finlay; William James Jonathan ; et al. | 2017-03-16 |
| Single domain binding molecule Grant 9,475,870 - Barelle , et al. October 25, 2 | 2016-10-25 |
| Anti-5t4 Antibodies And Uses Thereof App 20160185859 - BOGHAERT; Erwin R. ; et al. | 2016-06-30 |
| Single Domain Binding Molecule App 20160137726 - Barelle; Caroline ; et al. | 2016-05-19 |
| Use of tau to monitor immunotherapy Grant 9,272,030 - Black , et al. March 1, 2 | 2016-03-01 |
| Engineered Antibody Constant Regions for Site-Specific Conjugation and Methods and Uses Therefor App 20160008485 - Marquette; Kimberly ; et al. | 2016-01-14 |
| Antagonist Antibodies Against Gdf-8 App 20150152176 - Walsh; Frank S. ; et al. | 2015-06-04 |
| Use Of Tau To Monitor Immunotherapy App 20150118223 - Black; Ronald ; et al. | 2015-04-30 |
| Method for treating sarcopenia using antagonist antibodies against GDF-8 Grant 8,956,608 - Walsh , et al. February 17, 2 | 2015-02-17 |
| Anti-5t4 Antibodies And Uses Thereof App 20140308302 - BOGHAERT; Erwin R. ; et al. | 2014-10-16 |
| Anti-5T4 antibodies and uses thereof Grant 8,759,495 - Boghaert , et al. June 24, 2 | 2014-06-24 |
| Antagonist Antibodies against GDF-8 and Uses in Treatment of ALS and Other GDF-8 Associated Disorders App 20140086920 - Walsh; Frank S. ; et al. | 2014-03-27 |
| Single Domain Binding Molecule App 20130302250 - BARELLE; Caroline ; et al. | 2013-11-14 |
| Use Of Tau To Monitor Immunotherapy App 20130209453 - Black; Ronald ; et al. | 2013-08-15 |
| Method for treating cachexia using antagonist antibodies against GDF-8 Grant 8,496,934 - Walsh , et al. July 30, 2 | 2013-07-30 |
| Method For Treating Cachexia Using Antagonist Antibodies Against Gdf-8 App 20130156767 - Walsh; Frank S. ; et al. | 2013-06-20 |
| Polynucleotides encoding antagonist antibodies against GDF-8 Grant 8,372,625 - Walsh , et al. February 12, 2 | 2013-02-12 |
| Method for treating muscular dystrophy using antagonist antibodies against GDF-8 Grant 8,349,327 - Walsh , et al. January 8, 2 | 2013-01-08 |
| Immunotherapy Regimes Dependent On Apoe Status App 20120070379 - Black; Ronald ; et al. | 2012-03-22 |
| Anti-5t4 Antibodies And Uses Thereof App 20120064600 - BOGHAERT; Erwin R. ; et al. | 2012-03-15 |
| Antagonist Antibodies Against Gdf-8 And Uses In Treatment Of Als And Other Gdf-8 Associated Disorders App 20120016106 - Walsh; Frank S. ; et al. | 2012-01-19 |
| Antagonist Antibodies Against Gdf-8 And Uses In Treatment Of Als And Other Gdf-8 Associated Disorders App 20120003212 - WALSH; FRANK S. ; et al. | 2012-01-05 |
| Il-13 Binding Agents App 20110262435 - Tchistiakova; Lioudmila ; et al. | 2011-10-27 |
| Anti-5T4 antibodies and uses thereof Grant 8,044,178 - Boghaert , et al. October 25, 2 | 2011-10-25 |
| Nucleic acids encoding IL-13 binding agents Grant 7,943,342 - Tchistiakova , et al. May 17, 2 | 2011-05-17 |
| Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disorders Grant 7,910,107 - Walsh , et al. March 22, 2 | 2011-03-22 |
| Antagonist antibodies against GDF-8 Grant 7,888,486 - Walsh , et al. February 15, 2 | 2011-02-15 |
| Anti-cd20 Therapeutic Compositions And Methods App 20100330089 - Damle; Nitin K. ; et al. | 2010-12-30 |
| Immunotherapy Regimes Dependent On Apoe Status App 20100266505 - Black; Ronald ; et al. | 2010-10-21 |
| Humanized Anti-5t4 Antibodies And Anti-5t4/calicheamicin Conjugates App 20100173382 - Boghaert; Erwin R. ; et al. | 2010-07-08 |
| Humanized Anti-5t4 Antibodies And Anti-5t4/calicheamicin Conjugates App 20100021483 - BOGHAERT; ERWIN R. ; et al. | 2010-01-28 |
| Antagonist Antibodies Against Gdf-8 And Uses In Treatment Of Als And Other Gdf-8 Associated Disorders App 20090285827 - Walsh; Frank S. ; et al. | 2009-11-19 |
| Antibodies against human interleukin-13 and pharmaceutical compositions thereof Grant 7,615,213 - Kasaian , et al. November 10, 2 | 2009-11-10 |
| Il-13 Binding Agents App 20090274705 - Tchistiakova; Lioudmila ; et al. | 2009-11-05 |
| Ephrin And Eph Receptor Agonists For Modulation Of Bone Formation And Resorption App 20090186026 - Billiard; Julia ; et al. | 2009-07-23 |
| Immunotherapy Regimes Dependent On APOE Status App 20090155256 - Black; Ronald ; et al. | 2009-06-18 |
| IL-13 binding agents Grant 7,501,121 - Tchistiakova , et al. March 10, 2 | 2009-03-10 |
| Methods and Compositions for Antagonism of RAGE App 20070286858 - Clancy; Brian ; et al. | 2007-12-13 |
| Anti-5t4 Antibodies And Uses Thereof App 20070231333 - BOGHAERT; Erwin R. ; et al. | 2007-10-04 |
| Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders App 20070087000 - Walsh; Frank S. ; et al. | 2007-04-19 |
| Ligand for vascular endothelial growth factor receptor Grant 7,112,654 - Tchistiakova , et al. September 26, 2 | 2006-09-26 |
| Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugates App 20060088522 - Boghaert; Erwin R. ; et al. | 2006-04-27 |
| IL-13 binding agents App 20060073148 - Tchistiakova; Lioudmila ; et al. | 2006-04-06 |
| Antibodies against human interleukin-13 and uses therefor App 20060063228 - Kasaian; Marion T. ; et al. | 2006-03-23 |
| Ligand for vascular endothelial growth factor receptor App 20040266694 - Tchistiakova, Lioudmila ; et al. | 2004-12-30 |
| Ligand for vascular endothelial growth factor receptor Grant 6,733,755 - Tchistiakova , et al. May 11, 2 | 2004-05-11 |
| Ligand for enhancing oral and CNS delivery of biological agents Grant 6,696,274 - Tchistiakova , et al. February 24, 2 | 2004-02-24 |
| Ligand for enhancing oral and CNS delivery of biological agents App 20020137684 - Tchistiakova, Lioudmila ; et al. | 2002-09-26 |
| Ligand for vascular endothelial growth factor receptor App 20020058619 - Tchistiakova, Lioudmila ; et al. | 2002-05-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 